STARD13-IT1

Across TCGA pan-cancer cohorts, STARD13-IT1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated STARD13-IT1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher STARD13-IT1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated STARD13-IT1 expression acts as an unfavorable survival marker, although some lineages such as UCS and OV show a favorable association.

CESC, UCS, and KIRP are the cancer types where STARD13-IT1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	IV	0.167	0.612	.008	72	view →
UCS	OS	Quartile	All	0.719	0.225	<.001	50	view →
KIRP	OS	Tertile	All	0.727	0.925	.013	42	view →
OV	OS	Quartile	II,III,IV	0.765	0.669	.013	42	view →
MESO	OS	Tertile	II,III,IV	0.239	0.600	.018	36	view →
LUAD	DFS	Tertile	III,IV	0.840	0.569	.001	36	view →
UVM	DFS	Tertile	All	0.345	0.770	.020	36	view →
COAD	DFS	Tertile	All	0.729	0.804	.007	33	view →
HNSC	DFS	Tertile	III,IV	0.407	0.267	.017	33	view →
KIRC	DFS	Quartile	II,III,IV	0.395	0.705	.001	31	view →
LGG	DFS	Quartile	All	0.760	0.846	.004	17	view →
CHOL	OS	Quartile	III,IV	0.106	0.819	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

STARD13-IT1–CESC (OS)

Open the CESC breakdown →